Clinical Trial Update: Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1B trial of intratumoral cisplatin for stage IV non-small cell lung cancer is not yet recruiting. It represents early-phase exploration in metastatic dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: University of Vermont | Conditions: Lung Cancer Metastatic, Lung Cancer (NSCLC) | Phase 1 | Status: NOT_YET_RECRUITING